Research Article
Impact of HACOR Score on Noninvasive Ventilation Failure in Non-COPD Patients with Acute-on-Chronic Respiratory Failure
Table 1
Baseline data for patients who experienced successful NIV and NIV failure.
| | | Overall cohort, N = 148 | Successful NIV, N = 129 | NIV failure, N = 19 | |
| | Age, years | 64 ± 16 | 64 ± 16 | 67 ± 11 | 0.49 | | Sex, male | 83 (56%) | 71 (55%) | 12 (63%) | 0.62 | | APACHE II score | 16 ± 5 | 15 ± 4 | 20 ± 7 | <0.01 |
| | Diagnosis | | Sleep apnea-hypopnea syndrome | 52 (35%) | 48 (37%) | 4 (21%) | 0.12 | | Chronic thoracic sequelae | 34 (23%) | 28 (22%) | 6 (32%) | | | Bronchiectasis | 31 (21%) | 25 (19%) | 6 (32%) | | | Chest wall deformity | 14 (10%) | 14 (11%) | 0 (0%) | | | Obesity-hypoventilation syndrome | 5 (3%) | 3 (2%) | 2 (11%) | | | Others | 12 (8%) | 11 (9%) | 1 (5%) | |
| | Underlying disease | | Hypertension | 68 (46%) | 62 (48%) | 6 (32%) | 0.22 | | Chronic heart disease | 29 (20%) | 25 (19%) | 4 (21%) | >0.99 | | Diabetes mellitus | 28 (19%) | 23 (18%) | 5 (26%) | 0.36 | | Chronic renal failure | 11 (7%) | 9 (7%) | 2 (11%) | 0.63 | | Liver cirrhosis | 4 (3%) | 2 (2%) | 2 (11%) | 0.08 | | Duration of NIV (h) | 96 (42–143) | 103 (50–166) | 29 (3–77) | <0.01 | | Length of stay in the ICU (days) | 5.8 (3.7–10.8) | 5.5 (3.7–10.4) | 6.6 (3.4–13.2) | 0.79 | | Length of stay in the hospital (days) | 11.8 (6.8–19.0) | 11.8 (6.8–18.9) | 12.1 (7.6–21.8) | 0.88 | | Hospital mortality | 14 (10%) | 4 (3%) | 10 (53%) | <0.01 |
|
|
NIV, noninvasive ventilation; APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care unit.
|
